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Abstract
Genetic analyses of viral samples from 74 laboratory confirmed measles cases occurring in Taiwan
during 1992-2008 identified six viral genotypes D3, D5, D9, G2, H1 and H2. The most frequently
detected genotype, H1, was associated with outbreaks in 1994 and 2002, and was the likely
indigenous genotype in 1992. In response to the outbreaks, two catch-up campaigns were launched
and a routine second dose of measles, mumps, and rubella vaccine at entry to elementary school
was introduced. The vaccination campaigns successfully reduced the number of measles cases in
Taiwan, and many of the more recent cases can be traced to importations, primarily from other
Asian countries. A number of measles genotypes which were associated with outbreaks in other
Asian countries were detected among the more recent cases. The more recent genotype H1
viruses had sequences that were identical to those currently circulating in China or associated with
international importation of virus.
Background
Measles is a contagious human disease caused by measles
virus (MeV). Symptoms include high fever, conjunctivitis,
coryza, cough, the appearance of Koplik spots on the buc-
cal mucosa and a maculopapular rash. Vaccination pro-
grams have dramatically reduced the incidence of measles
on a global scale [1,2]. Measles transmission has been
interrupted in the region of the Americas, and the Eastern
Mediterranean, European and Western Pacific Regions
have established elimination targets for the near future.
Despite the success of global measles vaccination pro-
grams, measles is still responsible for an estimated
245,000 deaths each year [3], with most of these deaths
occurring in developing countries. Sustained measles out-
breaks continue to occur in developed countries that have
failed to maintain a high level of population immunity
[4].
As part of laboratory-based surveillance for measles,
genetic characterization of circulating wild-type viruses
provides an important tool for mapping transmission
routes, documenting the elimination of endemic strains,
and distinguishing vaccine reactions from wild-type infec-
tions [5-11]. In a given country or region, a genotype is
considered endemic if it is consistently associated with
outbreaks over an extended time period. On the contrary,
the identification of multiple genotypes associated with a
limited number of outbreaks and/or sporadic cases is
more consistent with multiple importations of virus than
with endemic virus circulation. This pattern of measles cir-
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culation was described for the United States, Australia,
and Canada during the last decade [7,8,10,12,13].
Live attenuated measles vaccine was first introduced to
Taiwan in 1968, but no mass vaccination policy was
established. From 1978 to 1987, the vaccine was provided
to infants at both 9 and 15 months of age. In early 1988,
vaccination was scheduled for 12-months of age, but a
two-dose schedule (9 months and 15 months) was initi-
ated later in the year because an outbreak occurred, and
this policy continued until 1991. In 1992, one dose of
measles vaccine was given at 9-months and a second dose
of measles, mumps, and rubella vaccine (MMR) was
administered at 15-months. Two catch-up campaigns
were implemented to improve coverage rates in response
to small outbreaks. From 1992 to 1994, the campaign tar-
geted junior high school through preschool children
(birth cohort 1976/09 to 1990/09), while the campaign
of 2001 to 2004 was aimed at elementary school students
(birth cohort 1990/09 to 1994/09). The current two-dose
MMR program for 12-15 month old infants and first grad-
ers (6 years old) was implemented in 2006 [14]. The cov-
erage rates with the first dose of measles vaccine among
children aged 13-24 months was 84% in 1993-94, and the
second dose MMR coverage rate improved from 69% in
1993-94 to 80-85% in 1995. Verifying immunization for
all entrants to primary school started in 1991, and by
1995, the overall vaccine coverage with at least one dose
of MMR in primary schoolchildren was 96% [15].
In 1985, measles was listed as a reportable disease in Tai-
wan, but routine serologic confirmation of infection was
not started until 1991. In 2000, to strengthen measles sur-
veillance, laboratory confirmation was required for all
suspected cases. Starting in 2002, clinical specimens
including throat swabs, urine, and whole blood were also
obtained for virological surveillance.
In this study, the viral genotypes associated with 74 con-
firmed cases of measles that occurred in Taiwan between
1992 and 2008 were determined.
Sixteen sequences were obtained from viral isolates and
the others were obtained directly from clinical samples.
Therefore, this is the first report that describes the molec-
ular epidemiology of MeV in Taiwan.
Results
Epidemiology
Measles was listed as a reportable disease since 1985 and
information regarding measles infections before 1985 is
incomplete. From 1985 to 1992, four major measles out-
breaks occurred in Taiwan (Figure 1) in 1985 (2,219
cases), 1988 (1,386 cases), 1989 (1,060 cases) and 1992
(303 cases). The epidemic in 1985 resulted in 97 deaths
with reported case fatality rate of 4.4%, whereas the epi-
demic of 1988-89 was associated with 12 deaths and a
case fatality rate of 0.5%. The high mortality rates associ-
ated with the outbreaks in 1985 and 1989 were likely due
to under reporting of the cases. In an outbreak investiga-
tion among elementary and junior high schools in north-
eastern Taiwan in 1989, the reporting of measles by
physicians was only 6.1% [16]. Beginning in 1993, the
annual number of reported measles cases was below 100,
the annual number of laboratory confirmed measles cases
averaged 8.6, with a range of 0-33 cases. There were no
Measles surveillance and vaccination in Taiwan, 1968-2008 Figure 1
Measles surveillance and vaccination in Taiwan, 1968-2008. Figure shows numbers of reported cases (black bars) and 
laboratory confirmed cases (lines) by year. The dates of introduction of measles vaccination and changes in the measles vacci-
nation program, including campaigns, are indicated by the text and arrows. The year when measles became a reportable dis-
ease was 1985. The year when routine laboratory confirmation started was 1991, and the year when laboratory confirmation 
required was 2000.
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laboratory confirmed cases for years of 1995, 1996, 1999,
and 2004 (Figure 1).
Genotyping
Genetic analysis was conducted on 74 measles cases
(Table 1) and 4 vaccine reactions that occurred between
1992 and 2008. Genotype information on MeVs that cir-
culated in Taiwan before 1992 is not available. The six
genotypes were detected among the 74 measles cases
included D3, D5, D9, G2, H1, and H2 (Table 1). Four
sequences from genotype A were obtained from patients
who presented with rash following vaccination.
Molecular characterization
Genotype D3 was detected in five cases, and three of these
(1 in 2002, 2 in 2003) were travelers from the Philippines
(Figure 2). All of the genotype D3 sequences were placed
within the same cluster as the reference strain, Illinois.
USA/89.1, and more divergent from an earlier D3
sequence, MVs/Taipei.TWN/94 (AJ250068) [17], which
was closely related to the Japanese strains (D87485,
D87486, and D87490) detected in 1989.
Genotype D5 was detected in nine cases in Taiwan. Geno-
type D5 has been reported to be circulating in Thailand
and had been associated with cases in Japan and imported
cases in the USA [18,19]. The source of virus for three of
the cases (one each in 1992, 2000, and 2002) was not
identified. The other six cases had sequences that were
more closely related to the Bangkok reference strain than
to the Palau reference strain (Figure 2). Of these six cases
with genotype D5 detected, one case was imported from
Thailand, one from Germany, and the four more recent
cases in 2007-2008 were imported from Japan.
The genotype D9 sequence from 2003 was obtained from
a 25-year-old woman who had traveled to Japan for 10
days before onset of clinicalsymptoms. Three other D9
sequences were obtained in 2008, one was from 4 year old
girl who traveled to the Philippines 13 days before rash
appeared. The other two cases from 2008 were from the
same household including a 25 year old man who had
traveled to Thailand 10 days before rash onset and then
transmitted virus to his 10 months old niece. Genotype
D9 was initially detected in East Timor and Java, Indone-
sia [20,21] and has recently been associated with out-
breaks in Japan [22].
Genotype G2 was first identified in 1997 in Indonesia and
Malaysia [23,24]. The three genotype G2 viruses detected
in Taiwan in 1997 shared identical sequences and were
closely related to the sequence of the reference strain for
genotype G2, MVi/Amsterdam.NET/49.97 (AF171232),
which was isolated from secondary cases of measles asso-
ciated with an index case from Indonesia. Though the
source of the virus was not identified, a linkage to Indone-
sia or Malaysia is speculated (Figure 2).
Genotype H1 was detected in 50 of the 74 samples from
cases occurring during 1992-2008. In 1992, genotype H1
sequences belonged to two lineages within what has been
described as genotype H1, cluster 1 [25] (Figure 3). Two
H1 sequences obtained in 1993 were identical to one of
the sequences detected during the previous year (MVs/
Keelung.TWN/18.92/3). Four identical genotype H1
sequences were obtained from the Taoyuan area in 1994.
The only H1 sequence detected in 1997, MVs/Tai-
pei.TWN/36.97, was very closely related (99% identity) to
Chinese viruses detected in 1995, MVi/Hunan.PRC/
15.95/9 (DQ356792) and MVi/Hunan.PRC/18.95/18
(DQ356791). One genotype H1 sequence was detected in
2000, but information regarding the source of infection
was not available. During 2001, six cases were confirmed
as genotype H1. Three of these cases had traveled to China
7-21 days before onset of rash and the sequences from the
six cases were distributed over three different lineages
(Figure 3).
There were 26 measles cases confirmed by serology in
2002, and 10 cases were from a school outbreak that
occurred from September to October. There were 17 cases
with sequence information and 15 of the H1 sequences
belonged to 3 different lineages. Of those, 3 were
imported from China (MVs/Taipei.TWN/26.02, MVs/Tai-
pei.TWN/27.02, and MVs/Pingtung.TWN/33.02). Nine of
the H1 isolates associated with the 2002 outbreak (six of
these were either household or school clustering) had
identical sequences and formed a separate lineage (Table
1, Figure 3) which included identical sequences from
viruses isolated from Japan and China, MVi/Tokyo.JPN/
23.01 (AB095428), MVi/Fuji.JPN/21.02 (AB095430),
MVi/Kawasaki.JPN/36.01 (AB095429), MVi/Shanxi.PRC/
13.02/1 (DQ356858), and MVi/Shanghai.PRC/30.02/1
(DQ356839), suggesting that these viruses were intro-
duced by importation.
The genotype H1 sequence detected in 2003 was from an
eleven months old infant returning from a visit to China.
The two cases with genotype H1 in 2005 were in the same
family and there was no history of travel. The six genotype
H1 sequences detected in 2006-2007 were all imported
from China (Table 1). Among the eight genotype H1
sequences detected in 2008 (Table 1), four had a travel
history to China. The case associated with MVs/Kaohsi-
ung.TWN/45.08 was responsible for nosocomial trans-
mission in two hospitals and the index case represented
by MVs/Kaohsiung/52.08 was identified later. In this out-
break, eight cases were confirmed and only four had ade-
quate samples for PCR testing. One of the genotype H1
sequences obtained in 2008, MVs/Taoyuan.TWN/29.08,Virology Journal 2009, 6:219 http://www.virologyj.com/content/6/1/219
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Table 1: Genetic characterization of measles viruses in Taiwan, 1992-2008
Strain Designation Age (yy/mm) Specimen Genotype Accession 
numbera
Vaccination Comment
MVs/Taiwan/18.92/1 00/10 serum H1 AY737397 Unknown
MVs/Taiwan/18.92/2 10/02 serum D5 AY737398 Unknown
MVs/Keelung.TWN/18.92/3 04/02 serum H1 EU914228 Unknown
MVs/Taiwan/19.92 13/06 serum D3 EU914241 Unknown
MVs/Taiwan/22.92/1 01/09 serum H1 AY737399 Unknown
MVs/Taiwan/22.92/2 unknown serum H1 AY737400 Unknown
MVs/Taipei.TWN/11.93 02/10 serum H1 DQ380233 Unknown
MVs/Keelung.TWN/23.93 01/09 serum H1 EU914229 Unknown
MVi/Taoyuan.TWN/21.94 03/10 throat swab H1 AY737401 Unknown 1994 Taoyuan 
measles outbreak
MVi/Taoyuan.TWN/22.94 05/10 whole blood H1 AY737402 Unknown 1994 Taoyuan 
measles outbreak
MVi/Taoyuan.TWN/24.94/1 02/10 throat swab H1 AY737403 Unknown 1994 Taoyuan 
measles outbreak
MVi/Taoyuan.TWN/24.94/2 03/08 whole blood H2 AY737404 Unknown 1994 Taoyuan 
measles outbreak
MVi/Taoyuan.TWN/24.94/3 03/10 throat swab H1 AY737405 Unknown 1994 Taoyuan 
measles outbreak
MVs/Taichung.TWN/21.97/1 01/00 serum G2 AY737406 Unknown
MVs/Taichung.TWN/21.97/2 00/05 serum G2 AY737407 No
MVs/Taichung.TWN/23.97 10/08 serum G2 AY737408 Unknown
MVs/Taipei.TWN/36.97 01/02 serum H1 AY737409 Unknown
MVs/Chiayi.TWN/13.98 01/07 serum H2 EU914239 Unknown Nosocomial
MVs/Chiayi.TWN/16.98 00/10 serum H2 EU914240 Yes Nosocomial
MVs/Taipei.TWN/11.00 00/10 serum D3 EU914242 No
MVs/Hualian.TWN/12.00 00/11 serum D5 AY737410 No
MVs/Taitung.TWN/21.00 27/07 serum H1 EU914230 Unknown
MVs/Taipei.TWN/07.01 28/09 serum H1 AY737411 Unknown Imported from 
China
MVs/Hsinchu.TWN/11.01/1 00/09 serum H1 AY737412 No
MVs/Hsinchu.TWN/11.01/2 00/08 serum H1 AY737413 No
MVs/Taipei.TWN/16.01 22/00 serum H1 AY737414 Unknown
MVs/Taoyuan.TWN/29.01 00/10 serum H1 AY737415 No Imported from 
ChinaVirology Journal 2009, 6:219 http://www.virologyj.com/content/6/1/219
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MVs/Taoyuan.TWN/45.01 00/09 serum H1 AY737416 No Imported from 
China
MVs/Taichung.TWN/10.02 01/00 serum D3 AY737417 No Imported from 
Philippines
MVs/Taipei.TWN/14.02 09/10 serum H1 AY737418 Yes
MVs/Kaohsiung.TWN/16.02 29/04 serum D5 AY737419 No
MVs/Taipei.TWN/26.02 00/07 urine H1 AY737420 No Imported from 
China
MVs/Taipei.TWN/27.02 00/10 throat swab H1 AY737421 No Imported from 
China
MVs/Pingtung.TWN/33.02 00/06 urine H1 AY737422 No Imported from 
China
MVs/Miaoli.TWN/34.02 27/04 urine H1 EU914225 Yes
MVs/Taichung.TWN/36.02/1 00/07 throat swab H1 AY737423 No
MVs/Taipei.TWN/36.02/2 26/01 urine H1 EU914227 Yes
MVs/Taichung.TWN/38.02 14/10 urine H1 AY737424 Yes Taichung outbreak, 
school clustering
MVs/Taichung.TWN/39.02/1 09/11 urine H1 EU914226 No Taichung outbreak, 
school clustering
MVs/Hsinchu.TWN/39.02/2 00/01 serum H1 AY737425 No
MVi/Taichung.TWN/40.02/1 13/02 urine H1 AY737427 Yes Taichung outbreak, 
school clustering
MVi/Taichung.TWN/40.02/2 09/11 urine H1 AY737428 Yes Taichung outbreak, 
school clustering
MVi/Taichung.TWN/40.02/3 13/03 whole blood H1 AY737429 Yes Taichung outbreak, 
school clustering
MVs/Hsinchu.TWN/40.02/4 29/00 serum H1 AY737426 Unknown
MVs/Taichung.TWN/41.02 13/11 urine H1 EU914244 Yes Taichung outbreak, 
school clustering
MVs/Hualian.TWN/18.03/1 00/10 serum D3 EU914243 No Philippines native
MVi/Hualian.TWN/18.03/2 00/10 whole blood D3 AY738084 No Philippines native
MVi/Taoyuan.TWN/20.03 00/11 throat swab H1 AY738085 No Imported from 
China
MVs/Taichung.TWN/45.03 28/10 urine D5 AY738086 Yes Imported from 
Thailand
MVs/Yilan.TWN/48.03 25/01 throat swab/urine D9 AY738087 Unknown
MVi/Taipei.TWN/09.05 01/02 throat swab H1 EU914232 No Household
MVs/Taipei.TWN/10.05 02/00 urine H1 EU914231 No Household
MVs/Taipei.TWN/46.05 40/04 urine D5 EU914244 No German native
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MVs/Taipei.TWN/17.06 00/10 throat swab/urine H1 EU914233 No Imported from 
China
MVs/Tainan.TWN/21.06 00/10 urine H1 EU914234 No Imported from 
China
MVs/Taipei.TWN/39.06 25/08 throat swab/urine H1 EU914235 No Imported from 
China
MVs/Tainan.TWN/23/07/1 30/09 throat swab/urine D5 EU914245 No Imported from 
Japan
MVi/Taipei.TWN/23.07/2 26/05 throat swab/urine D5 EU914246 Unknown Imported from 
Japan
MVi/Taipei.TWN/30.07 00/10 urine H1 EU914236 No Imported from 
China
MVs/Tainan.TWN/31.07/1 00/07 urine H1 EU914237 No Imported from 
China
MVs/Tainan.TWN/33.07 01/02 throat swab/urine H1 EU914238 No Imported from 
China
MVs/Taipei.TWN/34.07 16/05 throat swab/urine D5 EU914247 Unknown Imported from 
Japan
MVs/Hualian.TWN/01.08 04/11 throat swab D9 GQ338669 No Imported from 
Philippines
MVi/Taipei.TWN/05.08 27/00 urine H1 GQ338670 Unknown Imported from 
China
MVs/Chayi.TWN/11.08 00/10 throat swab/urine H1 GQ338671 No Imported from 
China
MVs/Taipei.TWN/16.08 45/07 throat swab/urine H1 GQ338672 Unknown Imported from 
China
MVi/Taipei.TWN/17.08 32/07 urine D5 GQ338673 Unknown Imported from 
Japan
MVs/Taoyuan.TWN/29.08 22/11 throat swab H1 GQ338674 Unknown
MVs/Taipei.TWN/34.08/1 25/04 urine D9 GQ338675 Unknown Imported from 
Thailand
MVs/Taipei.TWN/34.08/2 00/10 throat swab/urine D9 GQ338676 No Household
MVs/Kaohsiung.TWN/45.08 01/05 throat swab H1 GQ338677 No Imported from 
China
MVs/Kaohsiung.TWN/47.08 04/05 throat swab H1 GQ338678 No Nosocomial
MVs/Kaohsiung.TWN/52.08 00/09 throat swab/urine H1 GQ338679 No Nosocomial
MVi/Kaohsiung.TWN/53.08 39/11 urine H1 GQ338680 No Nosocomial
a Indicates N gene Genbank accession number
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Phylogenetic analysis of the carboxyl terminal 456 nucleotides of the N gene sequences from measles virus cases in Taiwan,  1992-2008 Figure 2
Phylogenetic analysis of the carboxyl terminal 456 nucleotides of the N gene sequences from measles virus 
cases in Taiwan, 1992-2008. The dendrogram was created with MEGA 4.1 by the neighbor-joining method with 1000 boot-
strap replicates. The asterisks indicate cases imported from foreign countries. Several sequences with highest nucleotide blast 
search from GenBank (shown by italic) are also included. The reference strains recommended by WHO (shown by bold italic) 
also included for comparison. The tree on 2A shows all sequences with the part of the tree showing all genotypes except gen-
otypes H1 and H2 expanded for easier viewing on 2B. Genotypes detected in Taiwan are indicated on the tree of 2B.
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Phylogenetic analysis of the 456 nts coding for the COOH terminus of the N protein of measles viruses detected in Taiwan,  1992-2008, highlighting the sequences in genotype H1 Figure 3
Phylogenetic analysis of the 456 nts coding for the COOH terminus of the N protein of measles viruses 
detected in Taiwan, 1992-2008, highlighting the sequences in genotype H1. The dendrogram was created with 
MEGA 4.1 by the neighbor-joining method with 1000 bootstrap replicates. The asterisks indicate viruses detected from 
imported cases. Several closely related sequences with the highest nucleotide BLAST scores from GenBank are also included 
(italic). The reference strains recommended by WHO also included for comparison (bold italic). The tree in figure 3A shows all 
sequences with the part of the tree showing only genotypes H1 and H2 expanded for easier viewing in figure 3B. The two pre-
viously described clusters of genotype H1 [25], are represented by MVi/Shanxi.PRC/13.02/1 (DQ356858) for cluster 1 and 
MVi/Hunan.PRC/18.95/18 (DQ356791) and MVi/Hunan.PRC/15.95/9 (DQ356792) for cluster 2.
MVs/Taipei.TWN/39.06 *
MVs/Tainan.TWN/33.07 *
MVi/Taoyuan.TWN/20.03 *
MVi/Taipei.TWN/05.08 *
MVs/Taipei.TWN/17.06 *
MVs/Tainan.TWN/21.06 *
MVs/Chayi.TWN/11.08 *
MVs/Taiwan/22.92/2
MVs/Taiwan/18.92/1
MVi/Taipei.TWN/30.07 *
MVs/Taoyuan.TWN/29.08
MVs/Kaohsiung.TWN/45.08 *
MVs/Kaohsiung.TWN/52.08
MVi/Kaohsiung.TWN/53.08
MVs/Kaohsiung.TWN/47.08
MVs/Taipei.TWN/27.02 *
MVs/Pingtung.TWN/33.02 *
MVs/Hsinchu.TWN/11.01/1
MVs/Hsinchu.TWN/11.01/2
MVs/Taipei.TWN/7.01 *
MVi/Taoyuan.TWN/24.94/1
MVi/Taoyuan.TWN/24.94/3
MVi/Taoyuan.TWN/21.94
MVs/Taipei.TWN/14.02
MVi/Taoyuan.TWN/22.94
MVs/Taiwan/22.92/1
MVi/Taipei.TWN/09.05
MVs/Taipei.TWN/10.05
MVs/Keelung.TWN/23.93
MVs/Keelung.TWN/18.92/3
MVs/Taitung.TWN/21.00
MVs/Taipei.TWN/11.93
MVs/Taipei.TWN/16.08 *
MVs/Tainan.TWN/31.07/1 *
MVs/Taipei.TWN/16.01
MVs/Taoyuan.TWN/29.01 *
MVs/Hsinchu.TWN/39.02/2
MVi/Shanxi.PRC/13.02/1
MVi/Taichung.TWN/40.02/2
MVs/Taichung.TWN/41.02
MVi/Tokyo.JPN/23.01
MVi/Taichung.TWN/40.02/1
MVi/Taichung.TWN/40.02/3
MVs/Taichung.TWN/38.02
MVs/Taichung.TWN/39.02/1
MVs/Miaoli.TWN/34.02
MVs/Hsinchu.TWN/40.02/4
Hunan.CHN/93/7(H1)
MVi/Hunan.RPC/15.95/9(DQ356792)
MVs/Taipei.TWN/36.97
MVi/Hunan.RPC/18.95/18(DQ356791)
MVs/Taipei.TWN/36.02/2
MVs/Taichung.TWN/36.02/1
MVs/Taipei.TWN/26.02 *
MVs/Taoyuan.TWN/45.01 *
Beijing.CHN/94/1(H2)
MVs/Chiayi.TWN/16.98
MVs/Chiayi.TWN/13.98
MVi/Taoyuan.TWN/24.94/2
Hatay.VIE/23.98/02(AY026878)
Berkeley.USA/83(G1)
Gresik.INO/17.02(G3)
Amsterdam.NET/49.97(G2)
Mvs/Taichung.TWN/21.97/1
MVs/Taichung.TWN/21.97/2
MVs/Taichung.TWN/23.97
Ibadan.NIE/97/1(B3)
New York.USA/94(B3)
Yaounde.CAE/12.83(B1)
MVs/Madrid.SPA/94 SSPE(F)
Tokyo.JPN/84(C1)
Erlangen.DEU/90(C2)
Maryland.USA/77(C2)
Libreville.GAB/84(B2)
Edmonston-wt.USA/54(A)
MVs/Taichung.TWN/04.05
MVs/Tainan.TWN/31.07/2
MVs/Taipei.TWN/13.05
MVs/Taipei.TWN/01.07
Goettingen.DEU/71(E)
Bristol.UNK/74(D1)
New Jersey.USA/94/1(D6)
Johannesburg.SOA/88/1(D2)
Kampala.UGA/51.00/1(D10)
Victoria.AUS/12.99(D7)
Illinois.USA/50.99(D7)
Manchester.UNK/30.94(D8)
MVs/Yilan.TWN/48.03 *
MVs/Hualian.TWN/01.08 *
MVs/Yamagata.JPN/7.04/3(AB186909)
MVs/Taipei.TWN/34.08/1 *
MVs/Taipei.TWN/34.08/2
Victoria.AUS/12.99(D9)
Montreal.CAN/89(D4)
Palau.BLA/93(D5)
MVs/Taiwan/18.92/2
MVs/Hualian.TWN/12.00
MVs/Taipei.TWN/11.00
MVs/Taichung.TWN/10.02 *
MVs/Hualian.TWN/18.03/1 *
Mvi/Hualian.TWN/18.03/2 *
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MVs/Taichung.TWN/39.02/1
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was detected by the laboratory surveillance system but no
source was identified. A search of GenBank found an iden-
tical sequence from case reported in Hong Kong, MVs/
HongKong.CHN/17.08 (EU870594). Therefore, there
were multiple introductions of genotype H1 viruses into
Taiwan from China and the epidemiologic information
documented importation for 17 of 50 cases. The
sequences from the recent genotype H1 viruses that were
imported into Taiwan showed 100% sequence identity
with genotype H1 viruses that were circulating in China or
were associated with international importation of virus.
For example, MVs/Tainan.TWN/33.07 (EU914238) had
100% identity with MVi/Sichuan.PRC/28.04/1
(EU557230) and MVi/Chongqing.PRC/20.04/1
(EU557209). MVs/Tainan.TWN/31.07/1 (EU914237)
shared identical sequences with MVs/Aberdeen.GRB/
10.06 (EF079131), MVi/Shanghai.PRC/22.06/11
(DQ902857) and MVs/Oregon.USA/8.06 (DQ888762).
Among the 50 H1 sequences characterized, forty-five cases
were clustered with the reference strain for genotype H1
(Figure 3) and the other five cases, displayed in a separate
lineage, were closely related to two genotype H1 viruses
from China, MVi/Hunan.PRC/18.95/18 (DQ356791)
and MVi/Hunan.PRC/15.95/9 (DQ356792).
Only three cases were confirmed to be associated with
genotype H2, one was in 1994 from the Taoyuan outbreak
and the other two were from an outbreak in a hospital in
1998. Although no information regarding the source of
these cases was available, these are more closely related to
the isolates from Vietnam [26].
Discussion
Historically, clade H of MeV was associated with Asian
countries, with genotype H1 being prevalent in China
[27], and genotype H2 linked to Vietnam [26]. Baseline
virological surveillance was not conducted in many Asian
countries so the exact distribution of the clade H viruses
in the pre-vaccine era is unknown.
This report contains the first analysis of the genetic char-
acteristics of MeVs circulating in Taiwan over the seven-
teen year period from 1992 to 2008. In Taiwan, measles
vaccination started in 1978, but epidemiologic informa-
tion was not available until 1991. Laboratory-based sur-
veillance was initiated in 1991, but routine virological
sampling did not occur until 2002. Before 2000, only
serum samples were collected and the percentage of sam-
pling from all reported cases was variable (range: 52% to
85%). The low sampling rate from 1995, 1996, and 1999,
of 59.5%, 59.6%, and 52.2% respectively, could have con-
tributed to the absence of confirmed measles cases for
those years.
Even though virological surveillance was not conducted in
Taiwan before 1992, the data presented here suggest that
MeV genotype H1, the most frequently detected genotype
in the study, represented the indigenous genotype in Tai-
wan. Genotype H1 viruses were detected almost every year
beginning in 1992 with the exception of 1995, 1996,
1998, 1999, and 2004 (Table 1). Importation of measles
from China was evident beginning in 2001 and accounted
for 10 of 14 detections of genotype H1 after 2006. It is
interesting to note that genotype H1 viruses were detected
in Taiwan before they were documented in China. It is
also possible that genotype D3, which was an indigenous
genotype in Asian countries including the Philippines,
could have been an endemic genotype in Taiwan at one
time [17] although D3 was only detected twice in 1992
and 2000.
Recent virological surveillance has documented the
spread of MeV in the Western Pacific Region. A large mea-
sles outbreak that occurred in Korea in 2000 was caused
by genotype H1 viruses [28] and genotypes H1 and D9
were imported into Japan [22,29-32]. The most recent
outbreaks in Japan were due to importation of genotype
D5 [33]. This report documents the importation of MeV
into Taiwan which began to introduce the foreign laborers
from countries of Indonesia, Malaysia, Philippines, Thai-
land, and Vietnam in the beginning of 1989. The number
of foreign workers reached 330,000 by end of 2006,
accounting for 1.4% of the total population. The multiple
genotypes and sporadic cases detected after 2003, except
for two cases in 2005, and one in 2008, were all docu-
mented to be the result of importation and the genotypes
detected, D3, D5, D9, G2, H1 and H2, are or were circu-
lating in nearby Asian countries. The observation that two
genotypes, H1 (4 cases) and H2 (1 case), were detected in
the 1994 outbreak implied that there were at least two dif-
ferent chains of transmission associated with the out-
break.
In the dendrogram derived from the N gene sequences
(Figure 3), two clusters of sequences within genotype H1
were observed. The majority of the sequences were more
closely related to the H1 reference strain and related
viruses have been detected on an ongoing basis in China
where this group of viruses is referred to as cluster 1 [25].
Five of the sequences from Taiwan, including MVs/Tai-
pei.TWN/36.97, MVs/Taoyuan.TWN/45.01, MVs/Tai-
pei.TWN/26.02, MVs/Taichung.TWN/36.02/1, and MVs/
Taipei.TWN/36.02/2, were clustered together and were
more distinct from H1 reference strain. This group of
viruses has also been detected in China and is referred to
as cluster 2 [25,34].
The diversity of genotypes and the low number of cases in
Taiwan is similar to what has been described in otherVirology Journal 2009, 6:219 http://www.virologyj.com/content/6/1/219
Page 10 of 11
(page number not for citation purposes)
countries that are in elimination phases of measles con-
trol [9,10,12,13]. The situation in Taiwan is different from
some other countries in the elimination phase because the
genotype H1 is continually being reintroduced by impor-
tation from neighboring Asian countries, so it is difficult
to document interruption of transmission of the sus-
pected indigenous genotype. However, both molecular
and epidemiologic data were used to link the more
recently detected genotype H1 viruses to international
importation. While virological surveillance will help to
document the sources of measles cases, formal documen-
tation of elimination will depend on meeting a number of
criteria, from both laboratory-based and epidemiologic
studies. Of course, the nosocomial measles outbreak that
occurred in 2008 highlighted the vulnerability of infants
younger than 12 months of age, unimmunized adults,
and the high risk of importation associated with interna-
tional travel. These events underscored the importance of
strengthening immunization programs, disease surveil-
lance, and laboratory confirmation.
Conclusion
This study reported the first analysis of the genetic charac-
teristics of MeVs circulating in Taiwan over the seventeen
year period from 1992 to 2008. Genetic analyses of viral
samples from laboratory confirmed measles cases identi-
fied six viral genotypes D3, D5, D9, G2, H1 and H2. Gen-
otype H1 remains the most frequently encountered MeV
transmitted among Asian countries. Recent measles cases
were epidemiologically linked to the importation from
foreign countries. These results highlight the importance
of integration of immunization programs, disease surveil-
lance systems, and laboratory diagnosis.
Materials and methods
Clinical Specimens
Specimens including throat swabs, urine, whole blood, or
serum were collected from suspected cases and tested in
the laboratory at the Taiwan CDC. During the period of
1992-2008, various specimens from 896 suspected
patients were collected for laboratory tests. Specimens
were processed with RT-PCR amplification from a total of
174 patients, including 42 with only one serum collected
at the acute phase and tested negative for measles IgM and
IgG, the other 132 cases were serologically confirmed with
positive measles IgM. Finally, 74 confirmed measles cases,
including 16 virus isolates, were sequenced and used for
genetic characterization. Here, a confirmed case is defined
serologically either by a positive IgM, or a significant rise
(4× or higher) of IgG titer between acute and convales-
cence phase, or a positive RT-PCR result from various clin-
ical samples (serum, throat swab or urine). Any confirmed
case that has travel history abroad 7-23 days before onset
of rash is classified as an imported case [35].
Serological Testing
Serum specimens were tested for measles IgM and IgG
antibodies using Enzygnost Anti-Marsen-Virus/IgM,
Enzygnost Anti-Marsen-Virus/IgG (Dade Behring, Mar-
burg, Germany) following the manufacturer's instruc-
tions.
Virus Culture
Clinical specimens including throat swab, urine sedi-
ments and lymphocytes were inoculated onto B95a cells,
a marmoset B lymphoblastoid cell line transformed by
Epstein-Barr virus [36], and observed for the presence of
cytopathic effect (CPE). Inoculated cells were blind pas-
saged up to two times before discarding those with no evi-
dent CPE.
Molecular Analysis of Measles Virus
RNA was extracted from infected cells or directly from
clinical specimens by using the Viral RNA mini kit (Qia-
gen Inc., Chatsworth, CA) following the manufacturer's
instructions. To obtain the sequence of the 450 nt region
of the measles N gene that is required for genotyping, RT-
PCR was performed by using a one-step RT-PCR kit (Qia-
gen) with reverse primer MV64 (nt 1719-1739, 5'-
TATAACAATGATGGAGGGTAG-3') and forward primer
MV59 (nt 866-889., 5'-GATATGTGACATTGATACAT-
ATAT-3'). Primer concentration was 0.4 μM each. The PCR
cycling conditions were reverse transcription at 50°C for
30 min, initial PCR activation step by 95°C for 15 min,
followed by 35 cycles of 30 s at 94°C, 30 s at 51°C and 1
min at 72°C, with a final extension for 5 min at 72°C. A
nested PCR was then performed on the resulting PCR
product of 873 bps using HotStartTaq Master Mix Kit
(Qiagen) with primers MV60 and MV63 (0.2 μM each) as
described elsewhere [37], and the cycling conditions were
95°C for 15 min followed by 30 cycles of 30 s at 94°C, 30
s at 63°C and 1 min at 72°C, with a final extension for 5
min at 72°C. Sequencing reactions were performed by
using the BigDye Terminator Cycle Sequencing Ready
Reaction kit (Applied Biosystems, Forster City, CA) with
the same primers as those used for the nested PCR. Nucle-
otide sequences were analyzed with MegAlign version
3.1.7. Phylogenetic trees were drawn with MEGA version
4.1 by neighbor-joining using 1000 bootstrap replicates.
The wild-type MeV isolates and genotype sequences from
Taiwan were named as recommended by WHO [38]. The
WHO-designated reference sequences [39] for each geno-
type were obtained from GenBank.
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CPE: cytopathic effect; N: Nucleoprotein.
Competing interests
The authors declare that they have no competing interests.Virology Journal 2009, 6:219 http://www.virologyj.com/content/6/1/219
Page 11 of 11
(page number not for citation purposes)
Authors' contributions
WYC carried out most of the studies and drafted the man-
uscript. LL participated parts of the studies and writing.
PAR provided consultation and editing of the manuscript.
DCY provided consultation and preparation of the final
report. All authors read and approved the final manu-
script.
Acknowledgements
We wish to thank Ms. Hsiao-Chi Wang who assisted in the serologic tests, 
and Mr. Yu-lin Ho who helped in processing of specimens. Thanks to Drs. 
Ming-Tsan Liu, Jyh-Yuan Yang, and Ho-Sheng Wu for their support and 
guidance. This study was supported in part by research grant from CDC 
Taiwan.
References
1. Progress in global measles control and mortality reduction,
2000-2007.  Wkly Epidemiol Rec 2008, 83:441-448.
2. Moss WJ: Measles control and the prospect of eradication.
Curr Top Microbiol Immunol 2009, 330:173-189.
3. Wolfson LJ, Strebel PM, Gacic-Dobo M, Hoekstra EJ, McFarland JW,
Hersh BS: Has the 2005 measles mortality reduction goal
been achieved? A natural history modelling study.  Lancet
2007, 369:191-200.
4. Moss WJ, Griffin DE: Global measles elimination.  Nat Rev Micro-
biol 2006, 4:900-908.
5. Global Measles and Rubella Laboratory Network, January
2004-June 2005.  MMWR Morb Mortal Wkly Rep 2005,
54:1100-1104.
6. Global distribution of measles and rubella genotypes--
update.  Wkly Epidemiol Rec 2006, 81:474-479.
7. Rota JS, Heath JL, Rota PA, King GE, Celma ML, Carabana J, Fernan-
dez-Munoz R, Brown D, Jin L, Bellini WJ: Molecular epidemiology
of measles virus: identification of pathways of transmission
and implications for measles elimination.  J Infect Dis 1996,
173:32-37.
8. Rota JS, Rota PA, Redd SB, Redd SC, Pattamadilok S, Bellini WJ:
Genetic analysis of measles viruses isolated in the United
States, 1995-1996.  J Infect Dis 1998, 177:204-208.
9. Rota PA, Featherstone DA, Bellini WJ: Molecular epidemiology of
measles virus.  Curr Top Microbiol Immunol 2009, 330:129-150.
10. Rota PA, Liffick SL, Rota JS, Katz RS, Redd S, Papania M, Bellini WJ:
Molecular epidemiology of measles viruses in the United
States, 1997-2001.  Emerg Infect Dis 2002, 8:902-908.
11. Rota PA, Rota JS, Redd SB, Papania MJ, Bellini WJ: Genetic analysis
of measles viruses isolated in the united states between 1989
and absence of an endemic genotype since 1994.  J Infect Dis
2001, 189(Suppl 1):S160-164.
12. Chibo D, Birch CJ, Rota PA, Catton MG: Molecular characteriza-
tion of measles viruses isolated in Victoria, Australia,
between 1973 and 1998.  J Gen Virol 2000, 81:2511-2518.
13. Tipples GA, Gray M, Garbutt M, Rota PA: Genotyping of measles
virus in Canada: 1979-2002.  J Infect Dis 2004, 189(Suppl
1):S171-176.
14. The CDC, Taiwan Website   [http://www.cdc.gov.tw]
15. Lee MS, Nokes DJ: Predicting and comparing long-term mea-
sles antibody profiles of different immunization policies.  Bull
World Health Organ 2001, 79:615-624.
16. Lee MS, King CC, Jean JY, Kao CL, Wang CC, Ho MS, Chen CJ, Lee
GC: Seroepidemiology and evaluation of passive surveillance
during 1988-1989 measles outbreak in Taiwan.  Int J Epidemiol
1992, 21:1165-1174.
17. Truong AT, Mulders MN, Gautam DC, Ammerlaan W, de Swart RL,
King CC, Osterhaus AD, Muller CP: Genetic analysis of Asian
measles virus strains--new endemic genotype in Nepal.  Virus
Res 2001, 76:71-78.
18. Multistate measles outbreak associated with an interna-
tional youth sporting event--Pennsylvania, Michigan, and
Texas, August-September 2007.  MMWR Morb Mortal Wkly Rep
2008, 57:169-173.
19. Rota PA, Bellini WJ: Update on the global distribution of geno-
types of wild type measles viruses.  J Infect Dis 2003, 187(Suppl
1):S270-276.
20. Update of the nomenclature for describing the genetic char-
acteristics of wild-type measles viruses new genotypes and
reference strains.  Wkly Epidemiol Rec 2003, 78:229-232.
21. Chibo D, Riddell M, Catton M, Birch C: Novel measles virus gen-
otype, East Timor and Australia.  Emerg Infect Dis 2002,
8:735-737.
22. Mizuta K, Abiko C, Murata T, Yamada K, Ahiko T, Sakamoto M,
Tsuchida S, Matsuzaki Y, Hongo S, Sunagawa T, Kudo K: An out-
break of measles virus infection due to a genotype D9 at a
junior high school in Yamagata, Japan in 2004.  Jpn J Infect Dis
2005, 58:98-100.
23. de Swart RL, Wertheim-van Dillen PM, van Binnendijk RS, Muller CP,
Frenkel J, Osterhaus AD: Measles in a Dutch hospital intro-
duced by an immuno-compromised infant from Indonesia
infected with a new virus genotype.  Lancet 2000, 355:201-202.
24. Rota PA, Liffick S, Rosenthal S, Heriyanto B, Chua KB: Measles gen-
otype G2 in Indonesia and Malaysia.  Lancet 2000,
355:1557-1558.
25. Zhang Y, Zhu Z, Rota PA, Jiang X, Hu J, Wang J, Tang W, Zhang Z, Li
C, Wang C, Wang T, Zheng L, Tian H, Ling H, Zhao C, Ma Y, Lin C,
He J, Tian J, Ma Y, Li P, Guan R, He W, Zhou J, Liu G, Zhang H, Yan
X, Yang X, Zhang J, Lu Y, Zhou S, Ba Z, Liu W, Yang X, Ma Y, Liang
Y, Li Y, Ji Y, Featherstone D, Bellini WJ, Xu S, Liang G, Xu W: Molec-
ular epidemiology of measles viruses in China, 1995-2003.
Virol J 2007, 4:14.
26. Liffick SL, Thi Thoung N, Xu W, Li Y, Phoung Lien H, Bellini WJ, Rota
PA:  Genetic characterization of contemporary wild-type
measles viruses from Vietnam and the People's Republic of
China: identification of two genotypes within clade H.  Virus
Res 2001, 77:81-87.
27. Xu W, Tamin A, Rota JS, Zhang L, Bellini WJ, Rota PA: New genetic
group of measles virus isolated in the People's Republic of
China.  Virus Res 1998, 54:147-156.
28. Na BK, Shin JM, Lee JY, Shin GC, Kim YY, Lee JS, Lee JK, Cho HW,
Lee HJ, Rota PA, Bellini WJ, Kim WJ, Kang C: Genetic and anti-
genic characterization of measles viruses that circulated in
Korea during the 2000-2001 epidemic.  J Med Virol 2003,
70:649-654.
29. Kubo H, Iritani N, Murakami T, Haruki K: Isolation of a wild type
measles virus classified as genotype H1 in osaka city.  Jpn J
Infect Dis 2002, 55:177-179.
30. Kubo H, Iritani N, Seto Y: Co-circulation of two genotypes of
measles virus and mutual change of the prevailing genotypes
every few years in Osaka, Japan.  J Med Virol 2003, 69:273-278.
31. Nakayama T, Zhou J, Fujino M: Current status of measles in
Japan.  J Infect Chemother 2003, 9:1-7.
32. Zhou J, Fujino M, Inou Y, Kumada A, Aoki Y, Iwata S, Nakayama T:
H1 genotype of measles virus was detected in outbreaks in
Japan after 2000.  J Med Virol 2003, 70:642-648.
33. Morita Y, Suzuki T, Shiono M, Shiobara M, Saitoh M, Tsukagoshi H,
Yoshizumi M, Ishioka T, Kato M, Kozawa K, Ttanaka-Taya K, Yasui Y,
Noda M, Okabe N, Kimura H: Sequence and phylogenetic anal-
ysis of the nucleoprotein (N) gene in measles viruses preva-
lent in Gunma, Japan, in 2007.  Jpn J Infect Dis 2007, 60:402-404.
34. Ji Y, Zhang Y, Xu S, Zhu Z, Zuo S, Jiang X, Lu P, Wang C, Liang Y, Zheng
H, Liu Y, Mao N, Liang X, Featherstone D, Rota PA, Bellini WJ, Xu W:
Measles Resurgence Associated with Continued Circulation
of Genotype H1 Viruses in China, 2005.  Virol J 2009, 6:135.
35. Guris D: Module on best practices for measles surveillance.
WHO V&B 2001. 01.43
36. Kobune F, Sakata H, Sugiura A: Marmoset lymphoblastoid cells
as a sensitive host for isolation of measles virus.  J Virol 1990,
64:700-705.
37. Katz RS, Premenko-Lanier M, McChesney MB, Rota PA, Bellini WJ:
Detection of measles virus RNA in whole blood stored on fil-
ter paper.  J Med Virol 2002, 67:596-602.
38. Expanded Programme on Immunization (EPI). Standardiza-
tion of the nomenclature for describing the genetic charac-
teristics of wild-type measles viruses.  Wkly Epidemiol Rec 1998,
73:265-269.
39. New genotype of measles virus and update on global distri-
bution of measles genotypes.  Wkly Epidemiol Rec 2005,
80:347-351.